205 related articles for article (PubMed ID: 33931028)
1. Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
Parczyk J; Ruhnau J; Pelz C; Schilling M; Wu H; Piaskowski NN; Eickholt B; Kühn H; Danker K; Klein A
BMC Cancer; 2021 Apr; 21(1):481. PubMed ID: 33931028
[TBL] [Abstract][Full Text] [Related]
2. Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
Ruhnau J; Parczyk J; Danker K; Eickholt B; Klein A
BMC Cancer; 2020 Jul; 20(1):617. PubMed ID: 32615946
[TBL] [Abstract][Full Text] [Related]
3. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.
Stander XX; Stander BA; Joubert AM
Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
[TBL] [Abstract][Full Text] [Related]
6. Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells.
Verma A; Lam YM; Leung YC; Hu X; Chen X; Cheung E; Tam KY
J Pharm Pharmacol; 2019 Mar; 71(3):306-315. PubMed ID: 30362115
[TBL] [Abstract][Full Text] [Related]
7. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
Tong J; Xie G; He J; Li J; Pan F; Liang H
J Biomed Biotechnol; 2011; 2011():740564. PubMed ID: 21403907
[TBL] [Abstract][Full Text] [Related]
10. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
Bellat V; Verchère A; Ashe SA; Law B
BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
[TBL] [Abstract][Full Text] [Related]
13. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
14. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines.
Yang Z; Tam KY
Eur J Pharmacol; 2016 Oct; 789():458-467. PubMed ID: 27514773
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of S6K1 enhances dichloroacetate-induced cell death.
Hong SE; Shin KS; Lee YH; Seo SK; Yun SM; Choe TB; Kim HA; Kim EK; Noh WC; Kim JI; Hwang CS; Lee JK; Hwang SG; Jin HO; Park IC
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1171-9. PubMed ID: 25471732
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis.
Skeberdytė A; Sarapinienė I; Krasko JA; Barakauskienė A; Žilionytė K; Prokarenkaitė R; Sužiedėlis K; Bukelskienė V; Jarmalaitė S
Biochem Biophys Res Commun; 2020 Mar; 523(4):874-879. PubMed ID: 31955885
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]